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The tumor suppressor TERE1 (UBIAD1) prenyltransferase
regulates the elevated cholesterol phenotype in castration
resistant prostate cancer by controlling a program of ligand
dependent SXR target genes.
William J. Fredericks1, Jorge Sepulveda2, Priti Lal3, John E. Tomaszewski4, MingFong Lin5, Terry McGarvey6, Frank J Rauscher III7, S. Bruce Malkowicz1
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ABSTRACT:
Castrate-Resistant Prostate Cancer (CRPC) is characterized by persistent
androgen receptor-driven tumor growth in the apparent absence of systemic
androgens. Current evidence suggests that CRPC cells can produce their own
androgens from endogenous sterol precursors that act in an intracrine manner to
stimulate tumor growth. The mechanisms by which CRPC cells become steroidogenic
GXULQJWXPRUSURJUHVVLRQDUHQRWZHOOGH¿QHG+HUHLQZHGHVFULEHDQRYHOOLQNEHWZHHQ
the elevated cholesterol phenotype of CRPC and the TERE1 tumor suppressor protein,
a prenyltransferase that synthesizes vitamin K-2, which is a potent endogenous ligand
for the SXR nuclear hormone receptor. We show that 50% of primary and metastatic
prostate cancer specimens exhibit a loss of TERE1 expression and we establish a
correlation between TERE1 expression and cholesterol in the LnCaP-C81 steroidogenic
cell model of the CRPC. LnCaP-C81 cells also lack TERE1 protein, and show elevated
cholesterol synthetic rates, higher steady state levels of cholesterol, and increased
expression of enzymes in the de novo cholesterol biosynthetic pathways than the
non-steroidogenic prostate cancer cells. C81 cells also show decreased expression
of the SXR nuclear hormone receptor and a panel of directly regulated SXR target
JHQHVWKDWJRYHUQFKROHVWHUROHϓX[DQGVWHURLGFDWDEROLVP7KXVDFRPELQDWLRQ
RILQFUHDVHGV\QWKHVLVDORQJZLWKGHFUHDVHGHϓX[DQGFDWDEROLVPOLNHO\XQGHUOLHV
the CRPC phenotype: SXR might coordinately regulate this phenotype. Moreover,
TERE1 controls synthesis of vitamin K-2, which is a potent endogenous ligand for
SXR activation, strongly suggesting a link between TERE1 levels, K-2 synthesis and
SXR target gene regulation. We demonstrate that following ectopic TERE1 expression
or induction of endogenous TERE1, the elevated cholesterol levels in C81 cells are
reduced. Moreover, reconstitution of TERE1 expression in C81 cells reactivates SXR
and switches on a suite of SXR target genes that coordinately promote both cholesterol
HϓX[DQGDQGURJHQFDWDEROLVP7KXVORVVRI7(5(GXULQJWXPRUSURJUHVVLRQUHGXFHV
K-2 levels resulting in reduced transcription of SXR target genes. We propose that
TERE1 controls the CPRC phenotype by regulating the endogenous levels of Vitamin
K-2 and hence the transcriptional control of a suite of steroidogenic genes via the
SXR receptor. These data implicate the TERE1 protein as a previously unrecognized
OLQNDϑHFWLQJFKROHVWHURODQGDQGURJHQDFFXPXODWLRQWKDWFRXOGJRYHUQDFTXLVLWLRQ
of the CRPC phenotype.
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WHQ ĮKHOLFDO WUDQVPHPEUDQH GRPDLQV D &5$& PRWLI
(cholesterol recognition amino acid concensus), and
several solution exposed loops that constitute binding
interfaces for interacting proteins [32-34]. Protein
LQWHUDFWLRQVWXGLHVLGHQWL¿HG$32(7%/+0*&5DQG
SOAT1 as TERE1-interacting proteins, strongly suggesting
a role in cholesterol homeostasis [32-34]. TERE1 subcellular distribution encompasses a range of cholesterol
regulatory sites including endoplasmic reticulum, golgi,
and mitochondria. Reconstitution of TERE1 expression in
bladder, renal, and prostate tumor cell that have silenced
the endogenous gene results in strong inhibition of tumor
FHOOJURZWK5HPDUNDEO\JHUPOLQHPXWDWLRQVLQ7(5(
cause a rare disease of elevated corneal cholesterol and
lipid deposition called Schnyder’s Corneal Dystrophy,
SCD [31, 35], and these mutations alter binding to APOE,
+0*5 DQG 7%/ >@ +RZHYHU WKH PHFKDQLVPV
by which TERE1 modulates cholesterol homeostasis via
its direct protein interaction with mediators of synthesis
+0*5 VWRUDJH 62$7 DQGHIÀX[ $32( DUHQRW\HW
ZHOOGH¿QHGDQGXQGRXEWHGO\FRPSOH[
7KH UHFHQW LGHQWL¿FDWLRQ RI 7(5( DV WKH
prenyltransferase required for vitamin K-2 biosynthesis
provides a basis for understanding its multi-factorial
LQÀXHQFHRQWKHFHOOLQFOXGLQJHIIHFWVRQVWHURLGLRJHQHVLV
TERE1-mediated synthesis of vitamin K-2 clearly affects
lipid metabolism, redox balance and mitochondrial
IXQFWLRQ >@ 1XPHURXV VWXGLHV GHVFULEH WXPRU
cell growth inhibition based on the redox-cycling
DQG DON\ODWLQJ SURSHUWLHV RI YLWDPLQV . DQG .
suggesting a basis for TERE1 tumor suppressor activity
>@ $QRWKHU GLPHQVLRQ RI 7(5( DFWLYLW\ UHODWHV
to its mitochondrial localized activity: its Drosophila
homolog, heix, was found to enhance mitochondrial
HOHFWURQ WUDQVSRUW DQG $73 SURGXFWLRQ >@ D ¿QGLQJ
consistent with the bioenergetics of K-2 in anaerobic
bacteria and mitochondria [41, 42]. We recently
reported immuno-electron microscopic localization
RI 7(5( LQ PLWRFKRQGULD DORQJ ZLWK 7%/ DQG WKH
effects on mitochondrial trans-membrane potential, and
WKH JHQHUDWLRQ RI 526516 >@ 7(5( FDQ DOVR WKH
expression of nuclear genes: its product, vitamin K-2 is
DSRWHQWOLJDQGIRUDFWLYDWLQJWKH6;5QXFOHDUKRUPRQH
UHFHSWRUDQGKHQFH6;5WDUJHWJHQHV>@PDQ\RI
ZKLFKDUHZHOONQRZQWRHQFRGHHQ]\PHVLQWKHde novo
cholesterol biosynthetic pathway. We thus investigated
TERE1 function as a modulator of the elevated cholesterol
SKHQRW\SHRI&53&>@E\IRFXVLQJRQWKH
DELOLW\RIWKH7(5(SURGXFW.WRDFWLYDWH6;5WDUJHW
JHQHV ZKLFK UHJXODWH VWHURO DFFXPXODWLRQ >@ 2XU
¿QGLQJV SRLQW WR D NH\ UROH IRU 7(5( LQ PRGXODWLQJ
cholesterol and steroid accumulation in prostate tumors
as a means of regulating growth and progression of this
neoplasm.

INTRODUCTION
Prostate cancer remains the most common male
malignancy and the second most common form of male
cancer death [1-3]. The common characteristic of the
disease through its clinical progression is androgen
receptor activation, which is initially accomplished by
systemic androgens. Abrogation of this pathway is a
common clinical treatment, which becomes ineffective
as tumors overcome castration induced levels of
systemic androgens by autocrine stimulation of self
produced androgens or androgen receptor activation
through mutations (receptor promiscuity to ligands or
constitutive activation) [4]. Although the activation of
androgen bio-synthetic pathway enzymes in tumor cells
has been demonstrated recently [5-9], the metabolism of
baseline hormone precursors such as cholesterol are less
well understood throughout the progression of prostate
cancer. Fig. 1A lists some features of Castrate Resistant
Prostate cancers [4, 10, 11]. Both primary tumors and
cell line models are characterized by aggressive growth,
and elevated levels of intracellular cholesterol [12] which
can cause altered growth signaling [13, 14], inhibition
of apoptosis [15-19], and provide intracrine precursors
for steroidogenesis, resulting in activation of androgen
receptor driven target genes associated with proliferation
[5-9, 20] .
Cellular cholesterol levels are normally highly
regulated via a complex interplay between several
SURFHVVHVWUDQVSRUW LQÀX[DQGHIÀX[ GHQRYRV\QWKHVLV
WUDI¿FNLQJVWRUDJHUHF\FOLQJDQGFDWDEROLVPWRELOHDFLGV
and steroid hormones [21, 22]. Generally the SREBP
transcriptional regulator proteins activate genes for
FKROHVWHUROV\QWKHVLVDQGLQÀX[DQGWKH/;5DQG6;5
QXFOHDUUHFHSWRUVDFWLYDWHFKROHVWHUROHIÀX[KRZHYHUERWK
also regulate different aspects of fatty acid metabolism
>@/;5WDUJHWVFDQDOVREHFURVVUHJXODWHGE\6;5WKH
steroid and xenobiotic receptor, or activated by oxysterols
derived from the cholesterol pathway or by fatty acids [23@/;56;5SDWKZD\VDFWLYDWHWKHDSRSURWHLQFDUULHUV
such as APOAI, APOE, and the transporters such as the
ATP binding cassette proteins ABC-A1, -G1, -G4, -G5,
*DQG65%,WKURXJKZKLFKHIÀX[SURFHHGVWRPDWXUH
+'/ > @ 7KH PXOWLSOH ZD\V WKHVH QHWZRUNV PD\
be dysregulated in the context of tumor cell metabolic
UHSURJUDPPLQJGXULQJSURJUHVVLRQLVQRWFOHDUO\GH¿QHG
A reasonable assumption is that during progression
either gain or loss of function in oncogenes, or tumor
suppressor genes contributes to the elevated cholesterol
and steroidogenic phenotype of CRPC [28]. A new
candidate for this type of regulation is the TERE1 gene
DND UBIAD1  DW FKURPRVRPH S ¿UVW GLVFRYHUHG
in this laboratory as absent or diminished in a large
proportion of prostate, bladder and renal tumors [2933]. An overview of TERE1 protein function is shown
in Fig. 1B. The 338 amino acid TERE1 protein contains
www.impactjournals.com/oncotarget

1076

Oncotarget 2013; 4: 1075-1092

in human prostate cancers we conducted an immunohistochemical analysis using a custom human prostate
WXPRUPLFURDUUD\ 70$ WRH[DPLQH7(5(H[SUHVVLRQLQ
primary carcinoma compared to metastatic specimens. The
UHVXOWVRISULPDU\DQGPHWDVWDWLFFDQFHUVSHFLPHQV
XVLQJ D ZHOO GH¿QHG FKLFNHQ DQWL7(5(  
antibody [33] are summarized in Fig. 2. Overall TERE1

RESULTS:
TERE1 expression in metastatic prostate cancer:
To determine the frequency of TERE1 alteration

Figure 1: A. Features of advanced Castrate Resistant Prostate Cancer cells. The elevated cholesterol phenotype of advanced prostate

FDQFHUDIIHFWVJURZWKVLJQDOLQJDSRSWRVLVDQGVWHURLGRJHQHVLV7KH/Q&D3FHOOOLQH&ZDVGHULYHGIURPWKH&FORQHE\H[WHQGHGVHULDO
passage and has acquired an altered program of gene expression that permits androgen synthesis. We propose this includes a loss of TERE1
H[SUHVVLRQ7KLVPDQXVFULSWGHVFULEHVWKHUROHRI7(5(DQGLWVQRYHOOLQNWRSXR-mediated mechanisms of regulating sterol accumulation
LQFHOOV%7(5(DWWKHQH[XVRIFKROHVWHUROV\QWKHVLVVWRUDJHDQGHIÀX[2YHUYLHZRIYLWDPLQ.HIIHFWVRQFHOOXODUPHWDEROLVP
APOE is a carrier of vitamin K-1, cholesterol, and triglycerides that interacts with TERE1 and is involved in K-1 delivery as well as lipid
UHF\FOLQJDQGHIÀX[7(5(FRQYHUWV.WR.DWPXOWLSOHORFDWLRQVJROJL(5DQGPLWRFKRQGULD,Q(5DQGJROJL7(5(PD\LQWHUDFW
with HMGCR and SOAT1 thus affect cholesterol synthesis and storage. Based on redox-cyling the K-2 and K-3 quinones may create
UHDFWLYHR[\JHQVSHFLHV526DQGQLWULFR[LGH12,QPLWRFKRQGULD.SOD\VDUROHLQDSRSWRVLVHOHFWURQWUDQVSRUWDQGPD\SOD\DUROHLQ
mitochondrial bioenergetics in anaerobic environments. TERE1 synthesis of vitamin K-2 creates a potent endogenous activator of the SXR
QXFOHDUUHFHSWRUZKLFKWUDYHUVHVWRWKHQXFOHXVZLWK5;5DQGLVDPDVWHUUHJXODWRURIHQGRELRWLFOLSLGDQGIDWW\DFLGKRPHRVWDVLV3KDVH,
DQG,,HQ]\PHVDQGWUDQVSRUWHUVLQYROYHGLQGUXJPHWDEROLVPFOHDUDQFHDQGHIÀX[RIFKROHVWHURODQGVWHURLGV,QWKLVUHJDUG7(5(HOLFLWV
an anti-sterol program that may reverse the elevated cholesterol phenotype of CRPC.
www.impactjournals.com/oncotarget
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FHOOVVKRZHGDVLJQL¿FDQWUHGXFWLRQ  LQFKROHVWHURO
VXJJHVWLQJ D JUHDWHU UHOLDQFH RQ XSWDNH UDWKHU WKDQ
synthesis. In contrast, the cholesterol level in the C81
cells was only slightly reduced by growth in lipoproteindepleted FBS, suggesting they may have an elevated rate
of cholesterol synthesis. When the cells were cultured in
WKHSUHVHQFHRIORYDVWDWLQ 0 WRLQKLELWHQGRJHQRXV
cholesterol synthesis, the cholesterol level of the C81
FORQHZDVUHGXFHG E\ WRDJUHDWHUH[WHQWWKDQ&
aUHGXFWLRQ VXJJHVWLQJWKDW&FHOOVKDYHDJUHDWHU
potential for cholesterol synthesis. Overall this suggests a
correlation between TERE1 levels and cholesterol in the
C33 and C81 cells, which is consistent with their reported
VWHURLGRJHQLFSRWHQWLDO>@

staining was heterogeneous. The most obvious change
was observed as a loss of staining in the metastatic group.
TERE1 staining was absent in a quarter of the metastatic
VSHFLPHQV a  LQ FRQWUDVW WR RQO\ D PLQRULW\ RI
FDVHV   RI SULPDU\ VSHFLPHQV )RU ERWK SULPDU\
DQGPHWDVWDWLFRYHURIVSHFLPHQVVKRZHGFRPSOHWH
DEVHQFHRUORZOHYHOVRIVWDLQLQJKHQFHDUHGXFHG7(5(
H[SUHVVLRQ PD\ UHSUHVHQW D VLJQL¿FDQW SKHQRW\SH LQ
prostate cancer.

Endogenous TERE1 expression and cholesterol in
C81 cells:
7KH /Q&D3 SURVWDWH FDQFHU FHOO VXEOLQH &
was derived from its parental cell line, C33 and is a
widely accepted model for the CRPC phenotype based
on its ability to become steroidogenic when grown in
KRUPRQH IUHH FRQGLWLRQV  FKDUFRDO VWULSSHG VHUXP 
>@:HFRPSDUHGWKHHQGRJHQRXV7(5(OHYHOVLQWKH
& DQG & /Q&D3 FORQHV DQG IRXQG & WR H[SUHVV
D VLJQL¿FDQWO\ UHGXFHG OHYHO RI 7(5( )LJ  7RWDO
cholesterol levels of cell lysates were measured using the
ZHOOHVWDEOLVKHG$PSOH[5HGÀXRURPHWULFDVVD\UHODWLYH
to a dilution series of cholesterol standards using equal
amounts of protein [48]. When we measured the total
cholesterol levels in C81 cell lysates we found they were
HOHYDWHGE\FRPSDUHGWR&IURPFHOOVJURZQLQ
XQGHUIXOOVHUXPFRQGLWLRQV )%6 +RZHYHUZKHQ
cells were grown in lipoprotein-depleted FBS (which
limits import of serum derived cholesterol), the C33

Elevated cholesterol synthesis:
The elevated level of total cholesterol in C81 cells
led us to examine cholesterol synthesis via isotopotomer
analysis using incorporation of 13&DFHWDWH DQG /&
06 DQDO\VLV )LJ $ 7KH FKURPDWRJUDSKLF SHDN IRU
FKROHVWHUROZDVLGHQWL¿HGXVLQJDGHXWHUDWHGFKROHVWHURO
'FKROHVWHURO  DV DQ LQWHUQDO VWDQGDUG 7KH VXP RI
the areas of 13&ODEHOHGLVRWRSRPHUVZLWKP]RI
 FRHOXWLQJ ZLWK WKH FKROHVWHURO SHDN GLYLGHG E\
the total amount of cholesterol isotopomers, was used
as a measure of cholesterol synthesis. The lysates from
& FHOOV VKRZHG D  LQFUHDVH LQ WKH DPRXQW RI
newly synthesized cholesterol compared to C33 cells. To
determine the underlying causes of increased cholesterol

Figure 2: Reduced TERE1 staining in prostate carcinoma tissue micro-array. The representative labeling index groups

$EVHQW/RZ0HGLXPDQG+LJK EDVHGRQWKHLQWHQVLW\RIVWDLQLQJ[SHUFHQWDJHRIWXPRUFHOOVVWDLQLQJZLWKDQWL7(5(DQWLERG\ DI¿QLW\
SXUL¿HGFKLFNHQSRO\FORQDODJDLQVWDPLQRDFLGV 7(5(SURWHLQLVUHGXFHG DEVHQWRUORZ LQaKDOIRISULPDU\DQGPHWDVWDWLF
KXPDQSURVWDWHFDUFLQRPDVSHFLPHQV7(5(H[SUHVVLRQZDVDEVHQWLQRIPHWDVWDWLFOHVLRQVFRPSDUHGWRRISULPDU\VSHFLPHQV
VXJJHVWLQJORVVRI7(5(H[SUHVVLRQPD\EHDPDUNHUIRUDGYDQFHGGLVHDVH
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VSHFLPHQV(QGRJHQRXV7(5(DWaN'DZDVEDUHO\
detectable in either of the cells (Fig. 5). After transfection
of TERE1 mammalian expression plasmids or adenovirus
LQIHFWLRQ ZH HDVLO\ FRQ¿UPHG HFWRSLF H[SUHVVLRQ RI
7(5(LQ/Q&DS&3&DQG'8,FHOOOLQHVDQG
then measured total cell-derived cholesterol. As a positive
FRQWURO IRU JHQHV WKDW LQÀXHQFH FKROHVWHURO OHYHOV ZH
transfected an expression plasmid for constitutively
active SREBP1a or SREBP2. In these cells we observed
an increased cholesterol level with PC-3, and C81,
respectively, as would be expected. Elevated expression
RI7(5(SURWHLQLQ'8,3&RU/Q&D3&FHOOV
FDXVHG D VLJQL¿FDQWO\ UHGXFHG LQWUDFHOOXODU FKROHVWHURO
OHYHOVFRPSDUHGWRFRQWUROYHFWRU.QRFNGRZQWHFKQRORJ\
was used to reduce the endogenous cellular level of the
7(5(LQ&FHOOV6LJQL¿FDQWO\WKHPL51$VSHFL¿F
IRU7(5(FDXVHGDLQFUHDVHLQFKROHVWHUROOHYHORI
/Q&D3&FHOOO\VDWHVFRPSDUHGWRWKRVHWUDQVGXFHGZLWK
DUHIHUHQFHVFUDPEOHGPL51$FRQWURO7KXVXQGHUWKHVH
conditions, altered expression of TERE1 can modulate
cellular cholesterol levels [32, 33, 49]. As a precursor to
steroid synthesis, cholesterol has important implications
for prostate cancer and the loss of TERE1 expression may
be one of the changes acquired during progression to the
castrate resistant phenotype of advanced prostate cancer.

synthesis we conducted an RTPCR analysis of expression
of several enzymes involved in cholesterol synthesis and
PRELOL]DWLRQ WR PLWRFKRQGULD DV D ¿UVW VWHS LQ VWHURLG
synthesis (Fig 4B). We found that the expression of
SREBP2, HMGCS, FDPS, HMGCR, STAR, and CYP11A1
were all elevated in C81 relative to C33 cells. This is
consistent with the elevated cholesterol synthesis that we
observe.

Increased expression of TERE1 protein reduces
cellular cholesterol levels:
TERE1 protein levels were assessed in two
additional well-studied prostate cancer cell lines
originally derived from metastases, DUI45 and PC3, to
see if reduced levels of TERE1 in cell lines might be a
feature in common with some metastatic prostate cancer

TERE1 expression is inducible in LnCaP cell
clones:
The presence of vitamin D response elements
(VDREs) within the TERE1 promoter [50], and
the previously established inhibitory effects of
 GLK\GUR[\ YLWDPLQ'RQ/Q&D3FHOOJURZWK>
52] led us to examine the inducibility of endogenous
TERE1 expression and the resultant effects on cholesterol
LQ/Q&D3SURVWDWHFDQFHUFHOOFORQHV )LJ 7UHDWPHQW
RIFHOOVZLWK GLK\GUR[\ YLWDPLQ' Q0IRU
DSHULRGRIGD\V LQFUHDVHG7(5(SURWHLQOHYHOVDQG
GHFUHDVHG FHOO FKROHVWHURO LQ ERWK /Q&D3 FHOO FORQHV
although C81 was more sensitive to the cholesterol
reduction than C33. This further demonstrates that TERE1
H[SUHVVLRQOHYHOVLQÀXHQFHFKROHVWHUROOHYHOV0RUHRYHU
these data suggest the possibility that Vitamin D status in
humans may affect TERE1 levels and suggest a possible
therapeutic use of vitamins D and K2 in androgenindependent prostate cancer.
Overall our studies have found that either exogenous
or endogenously induced TERE1 expression can lead to
changes in cellular cholesterol in prostate cancer cell lines.
Given the established mechanistic connection between
vitamin K-2, the product of TERE1 prenyltransferase
activity, and K-2’s role as a ligand for the SXR nuclear
receptor, a master regulator of sterol metabolism and
homeostasis, we next investigated SXR target gene
expression in the C33 and C81 cell lines.

Figure 3: Endogenous TERE1 expression is reduced
and cholesterol is elevated in the LnCaP C81 cell model
of CRPC. 7KH/Q&D3SURVWDWHFDQFHUFHOOOLQH&VHUYHVDV
a model for the Castrate Resistant Prostate Cancer phenotype
based on its steroidogenic potential. C81 was derived from the
parental C33 clone which is not steroidogenic. Immunoblot
analysis with goat anti-TERE1 antibody showed that C81
H[SUHVVHV D UHGXFHG OHYHO RI 7(5( DQG KDV D  HOHYDWHG
cholesterol level. In lipid free growth media, C33 cholesterol
OHYHOVDUHVLJQL¿FDQWO\UHGXFHGEXW&OHYHOUHPDLQVXQFKDQJHG
suggesting C33 is more dependent on transport and C81 more
GHSHQGHQW RQ V\QWKHVLV DQGRU UHWHQWLRQ7KH FKROHVWHURO OHYHO
RI & ZDV UHGXFHG E\ ORYDVWDWLQ 0  WR D JUHDWHU H[WHQW
than C33 suggesting that C81 cells have a greater potential for
cholesterol synthesis.
www.impactjournals.com/oncotarget
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Figure 4: LnCaP C81 cells have elevated cholesterol synthesis. 4A. We examined cholesterol synthesis in C33 and C81 cell
FXOWXUHV YLD /&06 LVRWRSRPHU DQDO\VLV DIWHU LQFRUSRUDWLRQ RI 13C-acetate. The sum of the areas of 13&ODEHOHGLVRWRSRPHUV ZLWK P]
RIFRHOXWLQJZLWKWKHFKROHVWHUROSHDNGLYLGHGE\WKHWRWDODPRXQWRIFKROHVWHUROLVRWRSRPHUVZDVXVHGDVDPHDVXUHRI
FKROHVWHUROV\QWKHVLV&FHOOO\VDWHVVKRZHGDLQFUHDVHLQQHZO\V\QWKHVL]HGFKROHVWHUROFRPSDUHGWR&FHOOV%)OXLGLJP
RT-PCR analysis of C81 transcripts relative to C33 revealed elevated expression of several enzymes involved in cholesterol synthesis and
mobilization of cholesterol to mitochondria. Those genes with an asterix* are established SXR target genes.
www.impactjournals.com/oncotarget
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genes that are established SXR target genes are indicated
with an asterix*. The most immediate observation is
that in C81 cells, the SXR gene itself is expressed at
 RI WKH OHYHOV VHHQ LQ & FHOOV DQG WKDW  RI 
SXR WDUJHW JHQHV DOVR VKRZ ORZHUHG OHYHOV /RRNLQJ
PRUH GHHSO\ DW WKH IXQFWLRQV RI WKHVH JHQHV WKH ¿UVW
category of SXR targets are all involved in cholesterol
K\GUR[\ODWLRQ WKDW IRUP WKH R[\VWHURO HIÀX[ IRUPV RI
cholesterol (CYP7A1*, CYP7B1*, and CYP27A1*).
7KH QH[W VHW LQFOXGHV FKROHVWHURO HIÀX[ DQG WUDQVSRUW
proteins (ABCB1*, ABCG1*, SRB1*, CD36*, APOE,
DQG053 DOORIZKLFKDUHDWORZHUOHYHOVLQ&FHOOV
TERE1-mediated reductions in expression of these two
sets of genes could contribute to the elevated cholesterol
observed in C81 cells via the sum of multiple mechanisms
RIDFFXPXODWLRQ ,QFRQWUDVWWRUHSUHVVLRQRIPRVWHIÀX[
mechanisms, we do observe that the ABCA1* cholesterol

SXR target gene repression in C81 cells:
The steroid and xenobiotic nuclear receptor, SXR,
has roles in the regulation of endobiotic homeostasis
(sterols, lipids) and regulation of transporters involved
in xenobiotic clearance [25, 43]. We assembled a
comprehensive array of established target genes of SXR,
of LXR (which can be cross-regulated) and several genes
involved in the synthesis and catabolism of cholesterol
and androgens and tested their levels in the cell lines
GHVFULEHGDERYH>@7KHGLDJUDPLQ)LJ
VXPPDUL]HV RXU ¿QGLQJV WKDW GHSLFW WKH IROGGLIIHUHQFH
in gene expression of C81 cells as a ratio relative to C33
cells. The differences are depicted with a “+” for foldactivation and with a “-” for fold-repression. Values
were normalized as described in methods. Expression of

Figure 5: TERE1 protein expression decreases the cellular cholesterol levels in PC-3, DUI45 and LnCaP-C81 prostate
cancer cell lines. :HH[SUHVVHG7(5(SURWHLQVLQ3&'8,DQG/Q&D3&FHOOVYLDDGHQRYLUXVWUDQVGXFWLRQRUWUDQVIHFWLRQDQG

FRQ¿UPHGH[SUHVVLRQRIWKHaN'D7(5(SURWHLQVYLDLPPXQREORWV&KROHVWHUROZDVPHDVXUHGXVLQJWKH$PSOH[5HGDVVD\(FWRSLF
H[SUHVVLRQRI7(5(SURWHLQIRUKRXUVUHVXOWVLQDUHGXFHGOHYHORIFHOOXODUFKROHVWHUROFRPSDUHGWRXQWUHDWHGRU$GLACZ Vector
FRQWUROV0L51$PHGLDWHGUHGXFWLRQRI7(5(UHVXOWVLQDQHOHYDWLRQRIFHOOXODUFKROHVWHUROLQ/Q&D3&FHOOV
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transporter is activated in C81, underscoring the cell’s
QHFHVVLW\ WR PDLQWDLQ DQ HIÀX[ PHFKDQLVP WR NHHS
cholesterol levels below a toxicity threshold.) Another
set of repressed genes play a role in steroid catabolism
(AKR1C1*, UGT2B17*, UGT2B15*, and HSD17B2) and
includes several SXR targets. The expected effect would
be to stabilize androgen production and is consistent with
the steroidogenic potential of C81. We also note that the
AR target gene PSA is also elevated by more than twofold. (Under full serum growth conditions steroidogenesis
ZRXOG QRW EH H[SHFWHG WR WDNH SODFH KHQFH ZH DOVR
observed repression of SRD5A1, AKR1C3*, and
CYP17A1*, data not shown). Finally, we see a subset of
classic SXR target genes involved in lipid and fatty acid
metabolism is also repressed (HMGCS*, CPT1A*, SCD1*,
FASN*, CYP24A1*, and SREBP1). Overall, in addition to
induction of cholesterol synthesis genes, it appears that
repression of SXRDQGLWVWDUJHWJHQHVLVDVLJQL¿FDQWIDFWRU
in the C81 CRPC phenotype by virtue of its potential to
SUHVHUYHVWHUROVIURPHIÀX[DQGFDWDEROLVP

(C81-K-2). Interrogating the custom array of genes by
RTPCR revealed a dramatic reversal in expression of SXR
and its target genes. In Fig. 8 the fold expression change of
the C81 cells transduced with TERE1, or treated with K-2
is depicted relative to the C81 vector control. First, SXR
expression is increased 11.3-fold by TERE1 expression.
Consistently, we see that expression of SXR target* genes
 JHQHV  LV LQFUHDVHG E\7(5( DQG PDQ\ RI WKH
same genes are also increased by Vitamin K-2 across
each of the 4 groups. TERE1 or K-2 treatments activate
the set of classical SXR target genes that regulate fatty
acid and lipid metabolism (HMGCS*, CPT1A*, SCD1*,
FASN*, CYP24A1*, SREBP1 and VDR). Highly relevant
to the reversal of the elevated cholesterol phenotype of
CRPC, we observed increased expression of cholesterol
K\GUR[\ODWLRQ HQ]\PH DQG FKROHVWHURO HIÀX[ JHQHV
WKDWZRXOGVLJQL¿FDQWO\UHGXFHWKHFKROHVWHUROOHYHOVLQ
& FHOOV DQG OLNHO\ DFFRXQW IRU WKH 7(5(PHGLDWHG
cholesterol reduction we observe and potentially limit the
supply of sterol precursors for androgen synthesis. Also
evident is a dramatic increase in expression of androgen
catabolic genes (AKR1C1*, SULT2A*, UGT2B17*,
UGT2B15*, CYP3A4*, and HSD17B2). The predicted
QHWHIIHFWRIDOWHUDWLRQVLQWKHDEXQGDQFHDFWLYLW\RIWKHVH
HQ]\PHVZRXOGEHWKHHIÀX[LQDFWLYDWLRQRUEUHDNGRZQ
of DHT and its precursors, which could potentially
decrease AR activation driven proliferation (Fig. 9).
Overall, these data demonstrate that TERE1
expression can lead to regulation of SXR target genes
involved in lipid metabolism and is consistent with the
hypothesis that this is due to activation of SXR by TERE1PHGLDWHGV\QWKHVLVRI.>@

TERE1 or exogenous vitamin K-2 switches on an
anti-sterol suite of SXR target genes:
1H[W ZH H[WHQGHG RXU 573&5 DQDO\VLV WR
investigate the potential for TERE1 or vitamin K-2 to elicit
a change in SXR target gene expression. We analyzed
expression from parallel sets of C81 cells that had received
HFWRSLF$G7(5(H[SUHVVLRQYLUXVIRUKRXUV &
7(5( RUGRVLQJZLWKYLWDPLQ. 0 RYHUQLJKW

DISCUSSION:
Elevated Tumor cell Cholesterol and Prostate
Cancer:
Androgen ablation therapy has been limited by
the emergence of a “castrate resistant phenotype” in
PRVW DGYDQFHG SURVWDWH FDQFHU SDWLHQWV 5HFHQW ZRUN
demonstrates that androgen dependence may not be
exhausted by systemic castration and inhibition of
extragonadal sources of androgen. The demonstration
of de novo synthesis of androgens from cholesterol
SUHFXUVRUVDQGIURPSURJHVWHURQHLQ/Q&D3FHOOPRGHOVRI
castrate resistant prostate cancer, CRPC, underscores the
critical role of intracrine mechanisms as a potential driving
force in cancer progression in the castrate state [5-9]. The
focus on cholesterol as an intracrine steroid precursor of
progesterone in mitochondria is further relevant in light of
additional studies showing that mitochondrial cholesterol
levels are frequently elevated in prostate cancers and can
interfere with membrane associated signaling complexes

Figure 6: Endogenous TERE1 expression is inducible
in LnCaP cell clones. 7UHDWPHQWRIERWK&DQG&/Q&D3

FHOO FORQHV ZLWK GLK\GUR[\ YLWDPLQ '  Q0 IRU D
SHULRGRIGD\V LQFUHDVHG7(5(SURWHLQOHYHOVDQGGHFUHDVHG
cell cholesterol.
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required to trigger early mitochondrial apoptotic events,
and to regulate important pathways governing cell
SUROLIHUDWLRQ >   @ 7KH YHU\ VLJQDOLQJ
pathways now recognized as being cholesterol-dependent:
$57*)ȕ(*)0$3.(5.$3, and AKT, are well
FKDUDFWHUL]HGDVSURVWDWHFDQFHUUHOHYDQW>@7KXVLQ
addition to its role as a steroid precursor, cholesterol has
HPHUJHGDVDNH\PROHFXOHWRSURVWDWHFDQFHUSURJUHVVLRQ
>@

[32, 33, 49]. With this prostate cancer study, our TERE1
immunohistochemical analysis found TERE1 staining was
reduced or completely absent in over half of 50 primary
and metastatic specimens. TERE1 expression was absent
LQRIPHWDVWDWLFOHVLRQVFRPSDUHGWRRISULPDU\
specimens, suggesting further loss of TERE1 during
progression. Hence, a reduced expression of the TERE1
SURWHLQ RFFXUV ZLWK VXI¿FLHQW IUHTXHQF\ WR SRWHQWLDOO\
DIIHFWDVLJQL¿FDQWQXPEHURILQGLYLGXDOV
We also found a reduced TERE1 protein expression
OHYHOLQWKH/Q&D3&FHOOPRGHORIDGYDQFHG&53&
UHODWLYH WR WKH SDUHQWDO /Q&D3& FORQH IURP ZKLFK
LW ZDV GHULYHG /RZ OHYHOV ZHUH VLPLODUO\ REVHUYHG LQ
ERWK 3& DQG '8, FHOO OLQHV 7DNHQ WRJHWKHU WKHVH
observations suggest that TERE1 expression may
represent a liability to prostate tumor cell metabolism
during progression.

TERE1 expression in prostate cancer specimens
and cell lines:
Our objectives in this study were to gain further
insights into the role of the TERE1 protein in the
elevated cholesterol phenotype of advanced Castrate
Resistant Prostate Cancer, CRPC. Our initial interest
was precipitated by our earlier demonstration that
7(5( PHVVDJH ZDV UHGXFHG LQ a  RI   RI
human prostate cancer specimens [29, 30]. We have
also found similar TERE1 expression reduction in renal
clear cell cancers, another example of a tumor with an
elevated cholesterol phenotype and in bladder cancer

TERE1, Cholesterol and SXR target gene analysis
in LnCaP-C81 cells:
The relevance of TERE1 loss to the elevated
cholesterol phenotype of advanced prostate cancer is

Figure 7: LnCaP C81 cells exhibit reduced expression of SXR and SXR target genes involved in cholesterol and steroid
catabolism. Fluidigm RT-PCR Taqman assays were conducted to compare expression of SXR target genes in C33 and C81 cells. The
genes are sorted into functional categories and established SXR target genes are indicated with an asterix *. The fold-differences in gene
expression of C81 cells are depicted as a ratio relative to C33 with a “+” for fold-activation and with a “-” for fold-repression. SXR and
14 of 18 SXR target* genes are repressed in C81 cells. Repression of this suite of SXRWDUJHWJHQHVUHSUHVHQWVDVLJQL¿FDQWFRPSRQHQW
RIWKH&53&HOHYDWHGFKROHVWHUROSKHQRW\SHRI/Q&D3&FHOOVE\YLUWXHRIWKHFRPELQHGSRWHQWLDOWRSUHVHUYHVWHUROVIURPHIÀX[DQG
catabolism.
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PDQ\HQGRJHQRXVDQG[HQRELRWLFVXEVWUDWHV>@,W
exhibits promiscuous binding to DR-3, DR-4, DR-5, ERDQG(5UHVSRQVHHOHPHQWVLQWDUJHWJHQHSURPRWHUV
including those with well-established roles in modulation
RIFHOOXODUFKROHVWHUROHIÀX[VXFKDV/;5>@7KH
relevance of TERE1-mediated vitamin K prenyltransferase
DFWLYLW\ WR 6;5 DFWLYDWLRQ LV IXUWKHU VXEVWDQWLDWHG E\
a recent study showing that vitamin K-2 analogs with
increasing number of prenyl groups were more potent
OLJDQGV IRU 6;5PHGLDWHG WUDQVFULSWLRQDO DFWLYLW\ >
@(SLGHPLRORJLFDOVWXGLHVKDYHDOVRQRWHGDQLQYHUVH
DVVRFLDWLRQ EHWZHHQ YLWDPLQ . LQWDNH DQG WKH ULVN
RI SURVWDWH DQG RWKHU FDQFHUV >@ 6;5 UHJXODWLRQ RI
HQGRJHQRXVVWHUROPHWDEROLWHVPDNHVWKLVQXFOHDUUHFHSWRU
DKLJKSUR¿OHWDUJHWIRUKRUPRQHGHSHQGHQWWXPRUV>@

further based on previous studies from our laboratory
and others that have demonstrated the role of TERE1
as a central modulator of cholesterol homeostasis, at the
QH[XVRIFKROHVWHUROV\QWKHVLVVWRUDJHDQGHIÀX[7(5(
interacts with: APOE, a cholesterol, triglyceride, and
vitamin K transport protein, HMGR, a master cholesterol
biosynthetic regulatory enzyme, and SOAT1, a regulator
RI FKROHVWHURO VWRUDJH > @ %\ YLUWXH RI LWV
direct role in vitamin K-2 synthesis, TERE1 activates
the SXR nuclear receptor, a master regulator of lipid,
sterol and xenobiotic homeostasis, and drug metabolic
HQ]\PHVDQGWUDQVSRUWHUV>@8SRQELQGLQJ
WR D GLYHUVH QXPEHU RI OLJDQGV 6;5 KHWHURGLPHUL]HV
ZLWK 5;5 DQG FURVVUHJXODWHV WDUJHW JHQHV LQYROYHG LQ
oxidative, peroxidative, and reductive metabolism of

Figure 8: Ectopic TERE1 or Vitamin K-2 reactivate an anti-sterol suite of SXR target genes in C81 LnCaP cells
LQYROYHGLQFKROHVWHUROHIÀX[DQGVWHURLGFDWDEROLVP Fluidigm RT-PCR Taqman assays were conducted to evaluate expression

FKDQJHVLQ&FHOOVDIWHUHFWRSLF$G7(5(H[SUHVVLRQRUYLWDPLQ. 0 WUHDWPHQW7KHIROGGLIIHUHQFHVLQJHQHH[SUHVVLRQRI
WKH/Q&D3FHOOV&7(5( LQEOXH RU&. LQUHG LVGHSLFWHGDVDUDWLRUHODWLYHWR&FHOOVZLWKD³´IRUIROGDFWLYDWLRQDQG
ZLWKD³´IRUIROGUHSUHVVLRQ7(5(.DFWLYDWHGSXR in C81 cells and each of the SXR target* genes tested in this study. Activation
of this suite of SXRWDUJHWJHQHVUHSUHVHQWVDVLJQL¿FDQWDQWLVWHUROJHQHH[SUHVVLRQSURJUDPZLWKSRWHQWLDOWRRSSRVHWKH&53&HOHYDWHG
FKROHVWHUROSKHQRW\SHRI/Q&D3&FHOOVE\YLUWXHRILWVFRPELQHGSRWHQWLDOWRHIÀX[FKROHVWHURODQGFDWDEROL]HDQGURJHQV
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synthesis measured via 13C acetate incorporation into
QHZO\V\QWKHVLV]HGFKROHVWHURO(TXDOO\VLJQL¿FDQWLVWKH
GLPLQLVKHGH[SUHVVLRQRIWKH6;5WDUJHWJHQHD[LVWKDW
includes a panel of cholesterol hydroxylation (CYP7A1*,
CYP7B1*, and CYP27A1 DQGHIÀX[SURWHLQV ABCB1*,
ABCG1*, 65%*, CD36*, APOE DQG 053  DV ZHOO
as androgen catabolic enzymes (AKR1C1*, UGT2B17*,

Consequently, we have focused our investigation on
WKHFRUUHODWLRQRI7(5(ZLWKFKROHVWHUROOHYHOVDQG6;5
WDUJHWJHQHVXVLQJWKH/Q&D3&FHOOPRGHORIWKH&53&
SKHQRW\SH >@ ,Q FRPSDULVRQ WR WKH QRQVWHURLGRJHQLF
C33 clone, C81 cells had increased expression of
FKROHVWHURO V\QWKHWLF HQ]\PHV 65(%3 +0*&6
)'36 DQG +0*&5  DQG DQ HOHYDWHG FKROHVWHURO

Figure 9: Overview of the Anti-Sterol targets activated by TERE1/vitamin K-2 in C81 LnCaP cells. TERE1 activates SXR
target genes (indicated by stars) that hydroxylate cholesterol (CYP7A1, CYP7B1, CYP27A1 WRIRUPR[\VWHUROHIÀX[IRUPVRIFKROHVWHURO
and activates a panel of transporters (ABCA1, ABCB1, ABCG1, SRBI, CD36, APOE, MRP2  WKDW SURPRWH FKROHVWHURO HIÀX[ IURP WKH
cell. Together these would serve to diminish cholesterol, the major precursor for androgen synthesis. TERE1 also turns on a program of
androgen catabolic enzymes with the following activities: CYP3A4K\GUR[\ODWHVWHVWRVWHURQHWKXVIDFLOLWDWLQJHIÀX[SULT2A sulfonates
DHT to a form that does not activate the Androgen receptor, HSD17B2 converts Testosterone to estrogen, AKR1C1 catabolizes DHT
by reduction to the inactive 3b andostanediol, and UGT2B15 and UGT2B17 glucuronidate the 3a andostanediol catabolite of DHT thus
SUHYHQWLQJLWVEDFNFRQYHUVLRQWR'+72YHUDOOWKLVVXLWHRI7(5(.SXR-driven activities executes an anti-sterol program that opposes
the CRPC phenotype.
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ULIDPSLFLQLQEUHDVWFDQFHUFHOOV>@0HQDGLRQH .
3) has also been shown to activate another cholesterol
WUDQVSRUWHU$%&* LQ +(. FHOOV ,PSDLUHG /;5
mediated regulation of ABCA1 and ABCG1 involved in
FKROHVWHUROHIÀX[KDVEHHQSURSRVHGDVDGHIHFWLQ/Q&D3
and PC3 prostate cancer cell lines that contributes to
FKROHVWHUROHOHYDWLRQ>@7KHLQKLELWLRQRI/Q&D3FHOO
[HQRJUDIWHGWXPRUVLQPLFHYLD/;5DJRQLVWVKDVEHHQ
SUHYLRXVO\DVVRFLDWHGZLWKHOHYDWLRQRI$%&$>@:H
also show that TERE1 protein expression can be induced
endogenously via 1,25-(dihydroxy)-vitamin D3 and result
in a decrease in cellular cholesterol. This is consistent
with the presence of VDREs in the TERE1 promoter, the
NQRZQH[SUHVVLRQRIWKH9'5LQ/Q&D3FHOOV>@
and early reports that calcitriol can reduce cholesterol
DQGLQKLELW+0*&5DFWLYLW\LQFXOWXUHGFHOOV>@7KH
ZHOONQRZQ FRUUHODWLRQ EHWZHHQ YLWDPLQ ' GH¿FLHQF\
and prostate cancer has evolved over many years of
epidemiological, cell and molecular studies [81]. The
active vitamin D metabolite, 1,25-(dihydroxy)-vitamin D3,
calcitriol, has been demonstrated to slow the progression
of prostrate cancer to advanced disease and inhibit growth
of many different prostate cancer cell lines. We noted that
1,25-(dihydroxy)-vitamin D3 caused a potent induction
 !IROG GDWD QRW VKRZQ  RI 68/7$ ZKLFK LV DQ
important mechanism for androgen inactivation [82]. In
addition to cholesterol, studies have shown that elevated
$%&% DOVR HIÀX[HV '+7 LQ /Q&D3 SURVWDWH FDQFHU
cells, which would further serve a role in anti-androgen
accumulation [83].

UGT2B15*, and HSD17B2) and several classic SXR
target genes involved in lipid and fatty acid metabolism
(HMGCS*, CPT1A*, SCD1*, FASN*, CYP24A1*, and
SREBP1  )LJVDQG $SSDUHQWO\WKH&&53&FHOOV
use multiple strategies to preserve the sterol precursors
and active androgens that their AR-driven proliferation is
GHSHQGHQWRQ,QFRQWUDVWWRRXU¿QGLQJVLQ/Q&D3&
cells, others have reported that ABCA1 is silenced
E\ SURPRWHU K\SHUPHWK\ODWLRQ LQ WKH SDUHQWDO /Q&D3
FHOOV >@ 7KLV PD\ DFFRXQW IRU LWV DSSDUHQW LQFUHDVH
LQ&ZKHQHYDOXDWHGUHODWLYHWRSDUHQWDO/Q&D3FHOO
,WDOVRPDNHVVHQVHWKDWWKHVWHUROHIÀX[SXPSABCA1*
remains actively expressed as a way to focus regulation
of potentially toxic sterol levels to a smaller set of pumps
for tighter control. All of these changes would serve to
SUHVHUYHVWHUROVIURPHIÀX[DQGFDWDEROLVPDQGFRQWULEXWH
to the elevated cholesterol phenotype of CRPC.

Vitamin K2/SXR and Cholesterol and Lipid
Metabolism:
Our investigation of the role of TERE1 in prostate
cancer supports the hypothesis of a vitamin K-2
mechanism for TERE1-mediated cholesterol modulation.
Upon restoration of TERE1 levels in C81 cells via ectopic
H[SUHVVLRQ )LJDQG ZH¿UVWQRWLFHGDQLQFUHDVHLQ
6;5 H[SUHVVLRQ DQG DOWKRXJK WKH H[DFW PHFKDQLVP RI
6;5LQGXFWLRQZDVQRWVWXGLHGKHUHLWLVFRQVLVWHQWZLWK
WKHNQRZQUHVSRQVHRIWKH6;5SURPRWHUWRFKDQJHVLQ
WKHPHWDEROLFÀX[RPH>@,QDGGLWLRQZHDOVRVHHWKH
H[SHFWHGDFWLYDWLRQRIWKHFRPSOHWH6;5D[LVFRQVLVWHQW
ZLWK WKH . DFWLYDWLRQ PHFKDQLVP RI 6;5 QXFOHDU
VLJQDOLQJ DQG WKH 6;5 LQFUHDVH ,Q PRVW FDVHV WKHUH LV
concordance between TERE1 and K-2 in the correlation
ZLWK DFWLYDWLRQ RI 6;5 DQG RWKHU WDUJHWV DOWKRXJK D
FXULRXVH[FHSWLRQLVWKH6;5P51$LWVHOIZKLFKZDVQRW
increased by K-2. The set of genes that were repressed in
the C81 basal state are now all switched on by TERE1:
these include the cholesterol hydroxylation (CYP7A1*,
CYP7B1*, and CYP27A1 DQGHIÀX[SURWHLQV ABCB1*,
ABCG1*, 65%*, CD36*, APOE DQG 053  7KLV
FKDQJHLQJHQHH[SUHVVLRQPRVWOLNHO\DFFRXQWVIRUWKH
TERE1-mediated cholesterol reduction we observe. Also
expected is the increased expression of SXR target genes
that regulate fatty acid and lipid metabolism (HMGCS*,
CPT1A*, SCD1*, FASN*, CYP24A1*, SREBP1), thus
UHLQIRUFLQJWKDWD.6;5PHFKDQLVPLVLQHIIHFW
2XU ¿QGLQJV DUH FRQVLVWHQW ZLWK VHYHUDO UHSRUWV
RI 6;5 DFWLYDWLQJ RQH RU DQRWKHU RI WKHVH WDUJHWV EXW
WKLV LV WKH ¿UVW GHPRQVWUDWLRQ RI 7(5(PHGLDWHG
HQGRJHQRXV.V\QWKHVLVVZLWFKLQJRQDVXLWHRI6;5
WDUJHWVLQSURVWDWHFDQFHUFHOOV$.6;5PHFKDQLVP
was demonstrated to increase expression of ABCB1
LQYROYHG LQ FKROHVWHURO HIÀX[ LQ RVWHREODVWLF FHOOV >
 @$%&% ZDV DOVR LQGXFHG E\ WKH 6;5 DJRQLVW
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TERE1 /Vitamin K2/SXR and androgen catabolism:
The next critical dimension of TERE1-mediated
expression changes relevant to the CRPC phenotype
concern the set of anti-androgenic targets of SXR that
KDYH GLPLQLVKHG DFWLYLW\ LQ /Q&D3 & FHOOV EXW DUH
turned on by TERE1 (AKR1C1*, SULT2A*, UGT2B17*,
UGT2B15*, CYP3A4*, and HSD17B2  2XU ¿QGLQJV
are supported by several reports highlighting the
UHOHYDQFH RI WKHVH WDUJHWV LQ DQGURJHQ FDWDEROLVP >@
7KH $.5& DQG $.5& HQ]\PHV DUH NQRZQ WR
play a role in catabolism of DHT (Fig 9.), and reduce
androgen-dependent growth [84]. AKR1C1 converts
ĮGLK\GUR[\WHVWRVWHURQHWRȕDQGURVWDQHGLRO$.5&
FRQYHUWV ĮGLK\GUR[\WHVWRVWHURQH DQG DQGURVWHURQH WR
ĮDQGURVWDQHGLRO%RWKRIWKHVHFDWDEROLFSURGXFWVDUH
unable to activate the androgen receptor [84, 85]. Impaired
catabolism by both AKR1C1 and AKR1C2 was found to
EHDFULWLFDOVWHSLQDQGURJHQVLJQDOLQJ>@7KHYLWDPLQ
.6;5PHFKDQLVPZDVSURYHQWRDFWLYDWHH[SUHVVLRQ
RI$.5&DQG$.5&LQRVWHREODVWLFFHOOV>@EXW
7(5(.PHGLDWHG DFWLYDWLRQ RI 6;5 KDV QRW EHHQ
SUHYLRXVO\VWXGLHGLQSURVWDWHFDQFHU68/7$D'+($
VXOIRWUDQVIHUDVHNQRZQWRFDXVHVXOIRQDWLRQRIDQGURJHQV
and reduce androgenic activity is another target activated
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E\ 7(5(6;5 /;56;5 DJRQLVWV ZHUH SUHYLRXVO\
VKRZQ WR DFWLYDWH 68/7$ LQ /Q&D3 FHOOV DQG LQKLELW
testosterone stimulated proliferation and PSA reporter
activity [82]. TERE1 activation of CYP3A4 is consistent
with reports of SXR-induced CYP3A4, which hydroxylates
testosterone and progesterone leading to inactive
metabolites and resulted in inhibition of androgenGHSHQGHQWJURZWKRIKXPDQ/$3&SURVWDWHFDQFHUFHOOV
> @ 7KH 8'3JOXFXURQRV\O WUDQVIHUDVH HQ]\PHV
8*7%DQG%DUHH[SUHVVHGLQSURVWDWHDQGNQRZQ
WRLQDFWLYDWHWHVWRVWHURQH'+7DQGĮDQGURVWDQHGLROE\
JOXFXURQLGDWLRQ>@8*7%DQG%DUHDFWLYDWHG
E\)2;$LQ/Q&D3FHOOVDQG6;5LVNQRZQWRLQWHUDFW
ZLWK)2;KRPRORJVDQGFURVVUHJXODWHWKHLUWDUJHWV
The predicted net effect of activity of these TERE1LQGXFHG HQ]\PHV ZRXOG EH WKH HIÀX[ LQDFWLYDWLRQ RU
EUHDNGRZQRI'+7DQGSUHFXUVRUVZKLFKZRXOGGHFUHDVH
AR activation driven proliferation (Fig. 9). Recently,
D QRYHO UROH IRU 6;5 DV D GLUHFW UHSUHVVRU RI DQGURJHQ
UHFHSWRU VLJQDOLQJ LQ '8, DQG /Q&D3 FHOO OLQHV ZDV
LGHQWL¿HG &RLPPXQRSUHFLSLWDWLRQ DQG FRORFDOL]DWLRQ
HYLGHQFHVXJJHVWHGDPRGHOLQZKLFK6;5DJRQLVWVDQG
$5 DQWDJRQLVWV FRXOG LQGXFH ELQGLQJ RI 6;5 ZLWK WKH
$5UHVXOWLQJLQ6;5PHGLDWHGUHSUHVVLRQRI$5WDUJHWV
>@7KLVVXJJHVWVWKHSRVVLELOLW\WKDW7(5(.6;5
may directly inhibit AR signaling in addition to the effects
reducing cholesterol and catabolizing AR-activating
androgens.
In summary, we have established a TERE1QHJDWLYHH[SUHVVLRQSKHQRW\SHWRRIKXPDQSURVWDWH
tumor specimens, correlated cholesterol synthesis and
accumulation in prostate cancer cell lines with TERE1
exogenous or endogenous expression. Furthermore, we
KDYH GH¿QHG DQ DQWLVWHURO VXLWH RI SXR target genes
SURPRWLQJFKROHVWHUROHIÀX[DQGDQGURJHQFDWDEROLVPWKDW
DUHUHSUHVVHGLQWKH/Q&D3&FHOOPRGHORI&53&EXW
are switched on by TERE1 expression and vitamin K-2.
The loss of TERE1 expression may be a defect that tumors
XVHWRXQFRXSOHYLWDPLQ.IURPQXFOHDU6;5VLJQDOLQJ
to permit elevation of cholesterol and facilitate androgen
driven progression. We believe TERE1 holds promise as
a new determinant in cholesterol-mediated progression of
prostate cancer and an exploitable modulator of androgen
metabolism to oppose CRPC.

VA) and grown according to supplier’s instructions. Goat
anti-TERE1 antibodies were obtained from Santa Cruz.
$I¿QLW\ SXUL¿HG SRO\FORQDO DQWLERGLHV DJDLQVW VSHFL¿F
peptide antigens of the human TERE1 (amino acids 229242) have been previously described [32, 33, 49].

Immunohistochemistry:
)LYHPLFURQVHFWLRQVIURPIRUPDOLQ¿[HGSDUDI¿Q
HPEHGGHG WLVVXH VSHFLPHQV ZHUH GHSDUDI¿QL]HG LQ
xylene and rehydrated in graded alcohol with quenching
of endogenous peroxidase activity by treatment with
+2LQPHWKDQRO7KHVOLGHVZHUHEORFNHGLQ
QRUPDOUDEELWVHUXPDQGLQFXEDWHGZLWKDI¿QLW\SXUL¿HG
DQWL7(5( XJPO IRUKRXUVDWoC. After washes,
the slides were incubated with biotin-conjugated rabbit
IgG for 30 minutes followed by streptavidin-conjugated
peroxidase and 3’3-diaminobenzidine, and counterstained with hematoxylin. The representative antiTERE1 staining levels were sorted into the four groups
(absent, low, medium and high) based on the based on the
assigned labeling index and are displayed in Fig 2. The
labeling index for each core was derived by multiplying
the percentage of positive cells by an intensity score (that
ranged from 0 to 3+). The average value obtained from
three cores was assigned as the score for that particular
case.

Expression vectors:
7KHPDPPDOLDQ&09H[SUHVVLRQSODVPLGS0
1)/$*7(5( WKH S$G&099'(677(5(
DGHQRYLUXV DQG PLFUR 51$ H[SUHVVLRQ SODVPLG IRU
10BB7(5(ZHUHSUHYLRXVO\GHVFULEHG>@
,QIHFWLRXV DGHQRYLUXV ZDV SURGXFHG DQG DPSOL¿HG LQ
HEK-293A cells following guidelines from Invitrogen
and tittered via an anti-hexon staining procedure from
Clontech to >4x108 ,8PO ,QIHFWLRQV ZHUH LQ WKH
SUHVHQFHRIJPOSRO\EUHQHDQGPRQLWRUHGYLD$GGFP
expression. All plasmids were sequenced to verify coding
sequences, point and deletion mutations, reading frames,
DQGZHUHDPSOL¿HGDQGSXUL¿HGE\VWDQGDUGWHFKQLTXHV
3ODVPLGV ZHUH TXDQWL¿HG E\ 89 DQG 3LFRJUHHQ DVVD\
(Invitrogen) and evaluated on ethidium bromide stained
agarose gels.

MATERIALS AND METHODS:

Transient transfection/expression analysis:
Cell lines and antibodies:
&HOOOLQHVZHUHWUDQVIHFWHGZLWKWKH1XFOHRIHFWRU,,
V\VWHPDFFRUGLQJWRWKHPDQXIDFWXUHU¶VSURWRFRO $PD[D
/RQ]D &RORJQH *HUPDQ\  ([SUHVVLRQ SODVPLGV ZHUH
FRQWUROOHG ZLWK SDUDOOHO WUDQVIHFWLRQV RI &09 HPSW\
vector. Cells were grown in 10cm dishes and harvested
after 1-3 days by washing in ice cold PBS, and scraping

7KH /Q&DS & DQG & FHOO FORQHV ZHUH
JHQHURXVO\ SURYLGHG E\ DQG FXOWXUHG DV VSHFL¿HG E\
'U 0LQJ)RQJ /LQ 8QLYHUVLW\ RI 1HEUDVND 0HGLFDO
Center). The PC3 and DUI45 cell lines were obtained
IURPWKH$PHULFDQ7\SH&XOWXUH&ROOHFWLRQ 0DQDVVDV
www.impactjournals.com/oncotarget
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in the presence of protease and phosphatase inhibitors to
freeze cell pellets. Preparation of whole cell extracts, BCA
protein assay, SDS-PAGE and immunoblotting procedures
have been described previously [32, 33].

C-acetate in cholesterol is proportional to the rate of
cholesterol synthesis.

RNA isolation, reverse transcription and Fluidigm
RT-PCR Taqman expression assays:

Cholesterol Assay:
&HOOV ZHUH JURZQ WR  FRQÀXHQF\ WUDQVGXFHG
ZLWK$G/$&=RU$G7(5(DQGa[HFHOOVZHUH
O\VHGLQPO7UL]RODIWHUKRXUV7RWDO51$ZDVLVRODWHG
from TRIzol cell lysates (Invitrogen, Carlsbad, CA),
XVLQJWKH$PELRQ3XUH/LQN51$0LQLNLWDFFRUGLQJWR
SURFHGXUHVVSHFL¿HGE\WKHPDQXIDFWXUHU &DWDORJ
$ 51$TXDQWLW\ZDVGHWHUPLQHGXVLQJD1DQRGURS
1'VSHFWURSKRWRPHWHU 7KHUPR6FLHQWL¿F:DOWKDP
0$  DQG TXDOLW\ ZDV DVVHVVHG XVLQJ DQ $JLOHQW 
Bioanalyzer (Agilent Technologies, Santa Clara, CA).
7KH F'1$ V\QWKHVLV VSHFL¿F WDUJHW SUHDPSOL¿FDWLRQ
and Fluidigm RTPCR Taqman expression assays were
performed using procedures recommended by ABI
Biosciences and Fluidigm (40) and were performed at
WKH 83(11 0ROHFXODU 3UR¿OLQJ )DFLOLW\ DV SUHYLRXVO\
described (24). Data was analyzed using the Fluidigm
%LR0DUN *HQH ([SUHVVLRQ 'DWD $QDO\VLV VRIWZDUH WR
REWDLQǻǻ&WYDOXHVDQGH[SUHVVHGDVDUDWLRWRWKH$G
vector control to determine the fold change in gene
expression.

The cholesterol content of cell lysates harvested
DIWHUKRXUVRIWUDQVGXFWLRQZLWK$GLACZ, Ad-TERE1,
RUWUHDWPHQWZLWKYLWDPLQ. 0 ZDVGHWHFWHGXVLQJ
DQ$PSOH[5HG&KROHVWHURO$VVD\NLWUHODWLYHWRDGLOXWLRQ
VHULHVRIFKROHVWHUROVWDQGDUGVDVVSHFL¿HG ,QYLWURJHQ 
/\VDWHVZHUHSUHSDUHGDVSUHYLRXVO\GHVFULEHG>@

Cholesterol synthesis analysis by LC-MS:
/Q&D3 FHOOV ZHUH SODWHG DW H   FP GLVK DQG
ZKHQFRQÀXHQW GD\V VHUXPZDVUHPRYHG
SODWHV ZDVKHG DQG FHOOV LQFXEDWHG LQ  OLSRSURWHLQ
GHSOHWHG VHUXP ZLWK  P0 1D 13&DFHWDWH IRU K
Cells were washed 2xPBS cold, harvested by scraping
in TBS with protease inhibitors and pellets were frozen.
)RUDQDO\VLVȝ/RI+2ZLWK)RUPLFDFLGZDV
added to the frozen pellets and sonicated on ice for 8’ at
F\FOHWLPH6DPSOHVUHFHLYHGȝ/RIPHWKDQRO
ZHUH YRUWH[HG DQG VKDNHQ IRU  PLQ DIWHU DGGLQJ 
ml of methyl tertiary-butyl ether. The top organic layer
ZDVFROOHFWHGDQGDGGHGWRLQMHFWLRQYLDOV7ZRȝ/VZHUH
injected into an Agilent 1200 liquid chromatographer and
analyzed by atmospheric pressure chemical ionization
$3&,  ZLWK DQ $JLOHQW %$ WULSOH TXDGURSROH
mass spectrometer. Chromatography conditions were
DV IROORZV ÀRZ UDWH   POPLQ PRELOH SKDVH ZDV
PHWKDQROZLWKIRUPLFDFLG )$ IRUPLQXWH
VZLWFKHGWRPHWKDQROZLWK)$IRUPLQXWHV
DQGUHHTXLOLEUDWHGLQPHWKDQROZLWK)$IRUDQ
additional 3 minutes. The stationary phase was a Zorbax
(FOLSVH 3OXV &  [  PP  ȝP SDUWLFOH VL]H
FROXPQ06FRQGLWLRQVZHUHDVIROORZVJDVWHPSHUDWXUH
&YDSRUL]HUWHPSHUDWXUH &JDVÀRZ O
PLQ QHEXOL]HU SUHVVXUH   SVL FDSLOODU\ YROWDJH 
9 SRVLWLYH FRURQD FXUUHQW   ȝ$ IUDJPHQWHU
YROWDJH 9,RQVZHUHDQDO\]HGE\DQ06VFDQIURP
WRP]7KHFKROHVWHUROSHDNZDVLGHQWL¿HGE\
XVLQJ DQ LQWHUQDO GHXWHUDWHG FKROHVWHURO VWDQGDUG '
cholesterol) on an aliquot of the sample extract and
SHUIRUPLQJSDUDOOHOWDQGHP0606LGHQWL¿FDWLRQRIWKH
P]WUDQVLWLRQVRIWRDQGWRIRU
XQODEHOOHG FKROHVWHURO DQG  WR  DQG  WR
IRU'FKROHVWHURO(DFKPROHFXOHRI&DFHWDWH
incorporated during cholesterol synthesis increases the
P]UDWLRRIWKHFKROHVWHUROPROHFXOHE\RQHFUHDWLQJD
series of isotopomers containing up to a maximum of 12
carbons derived from acetate C1 and 15 carbons from C2
[89]. The number of labeled carbons incorporated from
www.impactjournals.com/oncotarget

Taqman probes:
All Taqman gene expression assays for RT-PCR
ZHUH DV  )$0UHSRUWHU G\H 0*%QRQÀXRUHVFHQW
TXHQFKHU 1)4  IURP$SSOLHG %LRV\VWHPV ,QYLWURJHQ
Probes were inventoried assays selected to span an exon
junction and are listed: human BACTIN  ) 
GUSB  )  KXPDQ PPIA ) GAS6 ID:
+VBPAXL,'+VBPHMGCS ID:
+VBP&'SCARB3,'+VBP
CYP7A1,'+VBPAPOE,'+VB
m1, CPT1A,'+VBPFBXW7+VB
m1, INSIG1 ,' +VBP CYP11A1 ID:
+VBPSTAR,'+VBPTSPO ID:
+VBPSREBF1,'+VBPSREBF2
,'+VBPFASN,'+VBPSCD2
,'+VBP6&','+VBPST2A1
+VBPFDPS,'+VBPSXR ID:
+VBPTBL2,'+VBPUBIAD1
,' +VBP  ABCG1 ,' +VBP
ABCA1,'+VBPABCB1,'+VB
m1, CYP3A4 ,'+VBP AKR1C3 ID:
+VBP AKR1C2 ,' +VBP
AKR1C1,'+VBPSRD5A1,'+VB
P+ +6'% ,' +VBP OATP1B1 ID:
+VBP HMGR  ,' +VBP
CYP27A1  ,' +VBP CYP24A1 ID:
+VBP CYP17A1 ,' +VBP
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MRP2 ,'+VBPUGT2B15 ,'+V
UGT2B17 ,'+VBV+

Androgens and Androgen-Regulated Gene Expression
Persist after Testosterone Suppression: Therapeutic
Implications for Castration-Resistant Prostate Cancer.
&DQFHU5HVHDUFK  
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